Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REALizing and Improving Management of Stable COPD in China--A Multi-centre, Prospective, Observational Study to Realize the Current Situation of COPD Patients in China.

NCT03131362 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03131362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REALizing and Improving Management of Stable COPD in China--A Multi-centre, Prospective, Observational Study to Realize the Current Situation of COPD Patients in China.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2017
Completion date
August 6, 2020
Enrollment
5,020 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease copd